Treatment Options for EGFR T790M-Negative EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer

Corallo, S; D'Argento, E; Strippoli, A; Basso, M; Monterisi, S; Rossi, S; Cassano, A; Barone, CM

D'Argento, E (reprint author), Univ Cattolica Sacro Cuore, Dept Med Oncol, Fdn Policlin Univ Agostino Gemelli, Largo A Gemelli 8, I-00168 Rome, Italy.

TARGETED ONCOLOGY, 2017; 12 (2): 153

Abstract

The introduction of first- and second-generation EGFR-tyrosine kinase inhibitors (TKIs) (gefitinib, erlotinib and afatinib) for the treatment of advan......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索